^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SC-CAR4BRAIN

    i
    Other names: SC-CAR4BRAIN
    Associations

    News

    Trials
    Company:
    Seattle Children's Hospital
    Drug class:
    HER2-targeted CAR-T immunotherapy, B7-H3-targeted CAR-T immunotherapy, EGFR806-targeted CAR-T immunotherapy, IL-13Rα2-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    over1year
    Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors (clinicaltrials.gov)
    P1, N=72, Recruiting, Seattle Children's Hospital | Not yet recruiting --> Recruiting
    Enrollment open • CAR T-Cell Therapy
    |
    EGFR806-specific CAR T-cell therapy • SC-CAR4BRAIN